[HTML][HTML] Application of cross-species PET imaging to assess neurotransmitter release in brain
SJ Finnema, M Scheinin, M Shahid, J Lehto… - …, 2015 - Springer
Rationale This review attempts to summarize the current status in relation to the use of
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
Application of cross-species PET imaging to assess neurotransmitter release in brain.
SJ Finnema, M Scheinin, M Shahid, J Lehto… - …, 2015 - europepmc.org
Objectives Although PET radioligands are now available for more than 40 CNS targets, at
the initiation of the Innovative Medicines Initiative (IMI)" Novel Methods leading to New …
the initiation of the Innovative Medicines Initiative (IMI)" Novel Methods leading to New …
[引用][C] Application of cross-species PET imaging to assess neurotransmitter release in brain
SJ Finnema, M Scheinin, M Shahid, J Lehto… - …, 2015 - cir.nii.ac.jp
[PDF][PDF] Sjoerd J. Finnema, Mika Scheinin, Mohammed Shahid, Jussi Lehto, Edilio Borroni, Benny Bang-Andersen, Jukka
EW Sallinen - Psychopharmacology, 2015 - researchgate.net
Rationale This review attempts to summarize the current status in relation to the use of
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
Application of cross-species PET imaging to assess neurotransmitter release in brain
SJ Finnema, M Scheinin, M Shahid… - …, 2015 - search.proquest.com
Objectives Although PET radioligands are now available for more than 40 CNS targets, at
the initiation of the Innovative Medicines Initiative (IMI)" Novel Methods leading to New …
the initiation of the Innovative Medicines Initiative (IMI)" Novel Methods leading to New …
[HTML][HTML] Application of cross-species PET imaging to assess neurotransmitter release in brain
SJ Finnema, M Scheinin, M Shahid, J Lehto… - …, 2015 - ncbi.nlm.nih.gov
Objectives Although PET radioligands are now available for more than 40 CNS targets, at
the initiation of the Innovative Medicines Initiative (IMI)“Novel Methods leading to New …
the initiation of the Innovative Medicines Initiative (IMI)“Novel Methods leading to New …
Application of cross-species PET imaging to assess neurotransmitter release in brain
SJ Finnema, M Scheinin, M Shahid, J Lehto… - …, 2015 - go.gale.com
Rationale This review attempts to summarize the current status in relation to the use of
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
[PDF][PDF] Application of cross-species PET imaging to assess neurotransmitter release in brain
SJ Finnema, M Scheinin, M Shahid, J Lehto… - …, 2015 - core.ac.uk
Rationale This review attempts to summarize the current status in relation to the use of
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
[PDF][PDF] Application of cross-species PET imaging to assess neurotransmitter release in brain
SJ Finnema, M Scheinin, M Shahid, J Lehto… - …, 2015 - d-nb.info
Rationale This review attempts to summarize the current status in relation to the use of
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
Application of cross-species PET imaging to assess neurotransmitter release in brain
SJ Finnema, M Scheinin, M Shahid… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Rationale This review attempts to summarize the current status in relation to the use of
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …
positron emission tomography (PET) imaging in the assessment of synaptic concentrations …